Treatment
Pharmacological treatment clinical trials
We’re tracking 34 recruiting studies that include Pharmacological treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT07699029Recruiting
Clot removal for stroke in the back of the brain after 24 hours
This study tests a procedure to remove blood clots from large arteries in the back of the brain up to 14 days after a stroke starts. It may help people who have had a stroke more than a day ago and still have significant disability.
Wuhan, HubeiAges 18 years+ - NCT06024460Recruiting
Non-Drug vs Drug Therapy for Chronic Slipped Disc
This study compares non-medication treatments (like acupuncture and manual therapy) with standard pain medication for people with a slipped disc in the lower back that has lasted at least a month. It tests whether natural therapies can work just as well or better than drugs.
Seoul, Gangnam-GuAges 19–69 - NCT07477990RecruitingPhase 3
Testing a digital device for anxiety treatment
This trial is testing a digital device called Aurora that helps treat moderate to severe anxiety. It compares the device to standard anxiety medications, so you may receive either the device or a pill. The goal is to see if the device can work as well as medication without the side effects.
Mexico City, Mexico CityAges 18–65 - NCT07090200Recruiting
Rehabilitation program for COPD with heart or blood vessel disease
This study tests a rehabilitation program for people with COPD who also have heart or blood vessel problems. It aims to help you breathe better and improve your overall health.
Wuhan, HubeiAges 18 years+ - NCT07015944Recruiting
Moving on after breast cancer: a depression trial for survivors in Pakistan
This study tests a program called "Moving on After Breast Cancer" for women in Pakistan who have finished breast cancer treatment and now have depression. The goal is to see if this program helps them feel better emotionally.
Karachi, SindhAges 18 years+ - NCT06282848Recruiting
Myopia treatments for children ages 7 to 9
This study compares different ways to slow down nearsightedness (myopia) in children, including eyedrops and other treatments. It is designed for kids whose vision is getting worse and who are willing to join for 2 years.
Hong KongAges 7–9 - NCT05958875RecruitingPhase 4
Six-week medicine switch for schizophrenia after first treatment failure
This trial tests whether a more intensive medication approach for schizophrenia (or related conditions) helps people who didn’t improve on their first tried medicine. Participants will usually switch medicines and be compared against “treatment as usual.”
InnsbruckAges 18–70 - NCT05973786RecruitingPhase 3
Six-week medicine boost for bipolar depression after first treatment fails
This trial tests whether a stronger, more active medication plan for six weeks helps people with bipolar depression who did not improve with their first prescribed treatment. It compares the intensified medication plan to usual care to see which approach works better.
InnsbruckAges 18 years+ - NCT05973851RecruitingPhase 3
Six-week medicine boost for depression after first treatment failure
This study tests a more intensive antidepressant medicine approach for people whose first tried treatment didn’t work well enough. It compares the intensified treatment with usual care, aiming to improve depression symptoms and daily functioning.
InnsbruckAges 18–65 - NCT07402031Recruiting
Predicting weight loss from obesity treatments
This study looks at how people lose weight after medication or surgery for obesity. It helps predict which treatment might work best for you.
Brussels, Brussels CapitalAges 18–65 - NCT05603104RecruitingPhase 3
Medication intensification after first treatment failure in mood and psychosis
This Phase 3 study tests a stronger medication approach after your first current treatment hasn’t worked well enough. It targets people with schizophrenia, major depressive disorder, or bipolar depression who still have significant symptoms and life impact.
Ramat GanAges 18–70 - NCT07771530RecruitingPhase 2
Medication or dog therapy for PTSD symptoms
This study tests whether a combination of two medications (reboxetine and Ritalin) is more effective than dog-assisted therapy for reducing PTSD symptoms. Participation involves either taking the medications or attending dog therapy sessions.
HaifaAges 18–70 - NCT06335043Recruiting
Personalized medication matching for veterans with OSI
This trial tests whether using genetic information to guide medication choices can improve treatment for veterans with operational stress injuries (OSI). It aims to help find the right medication faster and with fewer side effects.
London, OntarioAges 18 years+ - NCT07278375Recruiting
Comparing treatments for babies with opioid withdrawal
This study looks at different medicine approaches to treat newborns with opioid withdrawal (NOWS). It compares how well babies do with standard care and may help find the best way to manage symptoms and support recovery.
Birmingham, AlabamaAges birth+ - NCT07701616Recruiting
Digital mindfulness therapy for obsessive-compulsive disorder
This study tests a smartphone-based mindfulness program to help people with obsessive-compulsive disorder (OCD) reduce their symptoms. If you have OCD and are between 12 and 65 years old, you may be able to join.
Changsha, HunanAges 12–65 - NCT03425669Recruiting
Using sound and balance exercises to help ADHD at school
This study tests whether adding specific sound and balance-related training at school can help children with ADHD. It may offer a non-medicine approach, and it also includes children without an ADHD diagnosis for comparison.
Lund, Skåne CountyAges 9–18 - NCT04666454RecruitingPhase 4
Medication trial for broken heart (Takotsubo) syndrome
This trial tests an optimized medication approach for people diagnosed with Takotsubo (“broken heart”) syndrome. It may help clinicians find a safer and more effective treatment plan after this heart condition.
AarhusAges 18 years+ - NCT06089603RecruitingPhase 4
CPAP for Sleep Apnea with High Red Blood Cells
This study tests whether CPAP therapy (a machine that helps keep your airway open while you sleep) can lower high red blood cell counts in people who have both sleep apnea and polycythemia. It may help reduce the need for other treatments.
Madrid, MadridAges 18–80 - NCT06410599RecruitingPhase 2
Medication boost for tough-to-treat chronic depression
This trial tests a new medication added to your current treatment for chronic depression that hasn't gotten better with at least two antidepressants and 12 therapy sessions. It might help when standard treatments aren't enough.
Tübingen, Baden-WürtembergAges 18–64 - NCT06529185Recruiting
Breathing device for COPD patients with leg pain
This trial tests if a breathing device (Breather) can help men with COPD who also have leg pain from blocked leg arteries (intermittent claudication) walk farther without pain. If you have both conditions, this study may offer a new way to improve your walking ability.
DokkiAges 50–60 - NCT07094438RecruitingPhase 1
Brain stimulation and neck surgery for severe Alzheimer's
This early-stage trial tests combining deep brain stimulation (a device that sends electrical pulses to the brain) with a neck surgery that aims to improve brain fluid drainage. It's for people with severe Alzheimer's who can still walk and do not have other major health issues.
BeijingAges 40–80 - NCT07149688Recruiting
Heart disease health program for older adults in Qujiang
This study follows older adults in Qujiang District who have chronic heart or blood vessel conditions. It aims to improve care through village-based management and help researchers better understand how to support long-term heart health.
Beijing, Beijing MunicipalityAges 60 years+ - NCT07603960Recruiting
Cold therapy to ease endometriosis pelvic pain
This study tests whether exposing your whole body to very cold air (below freezing) can reduce chronic pelvic pain from endometriosis and improve your quality of life. Endometriosis is a condition where tissue similar to the uterine lining grows outside the uterus, often causing pain.
Edinburgh, ScotlandAges 16 years+ - NCT06652776Enrolling by invitation
Italian COPD patient registry study
This study is creating a registry to better understand Chronic Obstructive Pulmonary Disease (COPD) in Italian patients. It will collect information from people with COPD to improve care and research.
Milan, MilanAges 40 years+
What Pharmacological treatment is being studied for
Conditions with recruiting Pharmacological treatment studies.
Common questions
- Are there clinical trials studying Pharmacological treatment?
- Yes. Clin2 currently lists 34 recruiting studies that include Pharmacological treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Pharmacological treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Pharmacological treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Pharmacological treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.